Hypertrophic Cardiomyopathy (HCM) is a genetic heart condition characterized by the thickening of the heart muscle, particularly the left ventricle. This thickening can impede the heart's ability to efficiently pump blood. HCM is often hereditary, and individuals with a family history of the condition are at an increased risk. While some people with HCM may experience no symptoms, others may suffer from chest pain, shortness of breath, or fatigue. In severe cases, HCM can lead to abnormal heart rhythms and an increased risk of sudden cardiac arrest. Diagnosis typically involves a combination of medical history, physical examinations, and diagnostic tests such as echocardiograms. Treatment options aim to alleviate symptoms and may include medications, lifestyle modifications, or, in extreme cases, surgical procedures. Regular monitoring and follow-up with healthcare providers are crucial for managing HCM and preventing complications.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation